Search for: "The Pill LLC"
Results 61 - 80
of 389
Sort by Relevance
|
Sort by Date
1 Aug 2020, 8:54 pm
Originally, Avandia was the top-selling diabetes pill in the world. [read post]
6 Jul 2020, 6:14 am
MedPage Today called the pills a “clear-cut fraud” while NBC News labeled them “a hoax. [read post]
6 Jul 2020, 6:14 am
MedPage Today called the pills a “clear-cut fraud” while NBC News labeled them “a hoax. [read post]
12 Jun 2020, 6:04 am
Sinkular and Don Kokoskie, Pay Governance LLC, on Thursday, June 11, 2020 Tags: Equity-based compensation, Executive Compensation, Firm performance, Incentives, Long-Term value, Ownership, Pay for performance [read post]
8 May 2020, 5:58 am
Securities and Exchange Commission, on Tuesday, May 5, 2020 Tags: COVID-19, Disclosure, Information environment, SEC, Securities regulation, Transparency Considerations on Non-Employee Director Compensation Posted by Brian Scheiring and Steve Pakela, Pay Governance LLC, on Wednesday, May 6, 2020 Tags: Boards of Directors, COVID-19, Director compensation, Equity-based compensation, Incentives, Say on… [read post]
1 May 2020, 6:02 am
A Look at the Data Behind Recent Poison Pill Adoptions Posted by Ethan Klingsberg, Paul Tiger and Elizabeth Bieber, Freshfields Bruckhaus Deringer LLP, on Friday, April 24, 2020 Tags: COVID-19, Hostile takeover, Mergers & acquisitions, Poison pills, Proxy advisors, Shareholder activism, Takeover defenses The Rise of the Aggressive Poison Pill Posted by Sanjay M. [read post]
3 Apr 2020, 6:03 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, April 3, 2020 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of March 27–April 2, 2020 The Impact of COVID-19 on Executive Compensation Posted by Greg Arnold and Todd Sirras, Semler Brossy Consulting Group, LLC, on Friday, March 27, 2020 Tags: Boards of Directors, COVID-19, Executive Compensation, Incentives, Market… [read post]
13 Mar 2020, 12:19 pm
Vital Silver, Quinessence Aromatherapy Ltd., N-ergetics, GuruNanda, LLC, Vivify Holistic Clinic, Herbal Amy LLC, and The Jim Bakker Show were hawking items by making the following claims—some of which suffer from overtly racist messaging, not amplified here. [read post]
13 Mar 2020, 7:40 am
ESSG LLC et al. and issued from the Ninth Circuit Court of Appeals. [read post]
10 Mar 2020, 10:47 am
The seven companies are: Colloidal Vitality LLC, GuruNanda LLC, Herbal Amy Inc., The Jim Bakker Show, Quinessence Aromatherapy Ltd., Vivify Holistic Clinic, and Xephyr LLC dba N-ergetics. [read post]
6 Mar 2020, 2:43 pm
Dana Kysztofiak worked as a Clinical Coordination Manager for HomeCare Maryland LLC. [read post]
6 Mar 2020, 11:29 am
Loss of your best friend - This is often one of the hardest pills to swallow after divorce. [read post]
5 Mar 2020, 2:04 pm
The case is Acetris Health LLC v. [read post]
4 Mar 2020, 11:31 am
The Centers for Medicare and Medicaid Services (CMS) has engaged a number of third-party, UPIC contractors (such as Qlarent, AdvanceMed, the CoventBridge Group, and SafeGuard Services LLC) to perform program integrity audits of Medicaid dental claims around the country. [read post]
1 Mar 2020, 9:23 am
The diversion of leftover or extra medication puts additional people at risk, with up to 20% of all opioid pills prescribed in the United States actually being taken for nonmedical reasons. [read post]
27 Feb 2020, 3:25 pm
Court of Appeals for the Federal Circuit issued its long-awaited decision in Acetris Health LLC v. [read post]
27 Feb 2020, 3:17 pm
In Acetris Health LLC v. [read post]
6 Feb 2020, 2:46 pm
On February 5, 2020, the FTC announced two settlements totaling nearly $3.4 million against Quantum Wellness Botanical Institute, LLC and their principals for claims made to older adults that the “ReJuvenation” pill was an “anti-aging wonder drug. [read post]
2 Jan 2020, 8:00 am
Investors, LLC, No. 2018 CA 000152 (Fla. [read post]
25 Nov 2019, 3:52 am
It is a bitter pill to swallow for many business owners and fiduciaries in New York to learn they must pay the legal fees they incur in proving their entitlement to advancement and/or indemnification. [read post]
